Literature DB >> 13541419

Ozone as a possible radiomimetic gas.

R BRINKMAN, H B LAMBERTS.   

Abstract

Entities:  

Keywords:  OZONE/effects

Mesh：

Substances：

Year:  1958        PMID： 13541419     DOI： 10.1038/1811202a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  [Effect of ozone upon mouse ascites tumor cells and upon chick fibroblasts in tissue culture].

Authors:  W Sachsenmaier; W Siebs; T A Tan
Journal:  Z Krebsforsch       Date:  1965

2.  Toxicity of fatty ozonides and peroxides.

Authors:  R Cortesi; O S Privett
Journal:  Lipids       Date:  1972-11       Impact factor: 1.880

3.  Ozone response in wild type and radiation-sensitive mutants of Saccharomyces cerevisiae.

Authors:  H Dubeau; Y S Chung
Journal:  Mol Gen Genet       Date:  1979-11

4.  Distinct enzymatic responses in mice exposed to a range of low doses of ozone.

Authors:  T S Veninga; J Wagenaar; W Lemstra
Journal:  Environ Health Perspect       Date:  1981-06       Impact factor: 9.031

Review 5.  Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted?

Authors:  Bernardino Clavo; Norberto Santana-Rodríguez; Pedro Llontop; Dominga Gutiérrez; Gerardo Suárez; Laura López; Gloria Rovira; Gregorio Martínez-Sánchez; Esteban González; Ignacio J Jorge; Carmen Perera; Jesús Blanco; Francisco Rodríguez-Esparragón
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-09       Impact factor: 2.629

6.  Ozonation of Whole Blood Results in an Increased Release of Microparticles from Blood Cells.

Authors:  Barbara Boczkowska-Radziwon; Piotr Józef Olbromski; Anna Rogowska; Magdalena Bujno; Marta Myśliwiec; Agnieszka Żebrowska; Dariusz Średziński; Barbara Polityńska; Marek Z Wojtukiewicz; Piotr Radziwon
Journal:  Biomolecules       Date:  2022-01-21

7.  Ozone Therapy for Tumor Oxygenation: a Pilot Study.

Authors:  Bernardino Clavo; Juan L. Pérez; Laura López; Gerardo Suárez; Marta Lloret; Victor Rodríguez; David Macías; Maite Santana; María A. Hernández; Roberto Martín-Oliva; Francisco Robaina
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.